Home ›
Trademark Categories ›
Pharmaceuticals ›
2010 ›
SE ›
SEEBRI
Trademark search for:
SEEBRI
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2017-04-12 — Application filed
2017-04-15 — Application filed
2017-04-19 — Application filed
2017-04-20 — Notice of design search code e-mailed
2017-04-27 — Assigned to examiner
2017-04-28 — Examiners amendment -written
2017-04-28 — Examiner's amendment entered
2017-04-28 — Notification of examiners amendment e-mailed
2017-04-28 — Examiners amendment e-mailed
2017-04-29 — Approved for pub - principal register
2017-06-07 — Assigned to lie
2017-06-15 — Law office publication review completed
2017-06-28 — Notification of notice of publication e-mailed
2017-07-18 — Published for opposition
2017-07-18 — Official gazette publication confirmation e-mailed
2017-09-12 — Noa e-mailed - sou required from applicant
2017-12-01 — Teas statement of use received
2017-12-01 — Use amendment filed
2017-12-15 — Case assigned to intent to use paralegal
2017-12-19 — Statement of use processing complete
2017-12-28 — Allowed principal register - sou accepted
2017-12-29 — Notice of acceptance of statement of use e-mailed
2018-01-30 — Registered-principal register
2023-01-30 — Courtesy reminder - sec. 8 (6-yr) e-mailed
2024-08-09 — Cancelled sec. 8 (6-yr)
2024-08-09 — Final status recorded
Owner Information
Novartis AG
Novartis AG
Novartis AG
Correspondent
MAURY M. TEPPER, III TEPPER & EYSTER, PLLC
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
